20858857Tallman MS, Kim HT, Montesinos P, Appelbaum FR, de la Serna J, Bennett JM, Deben G, Bloomfield CD, Gonzalez J, Feusner JH, Gonzalez M, Gallagher R, Miguel JD, Larson RA, Milone G, Paietta E, Rayon C, Rowe JM, Rivas C, Schiffer CA, Vellenga E, Shepherd L, Slack JL, Wiernik PH, Willman CL, Sanz MABloodAntineoplastic Combined Chemotherapy Protocols; Leukemia, Promyelocytic, Acute; Neoplasm Recurrence, LocalAdolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young AdultDoes microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. Blood. 2010 Dec 16; 116(25):5650-9.Blood2010-09-21T00:00:002010Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461294Aged, 80 and overD000293Living Beings111389680.400538AdolescentD000368Living Beings1341183530.294764AgedD000328Living Beings1578255770.254432AdultD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD002648Living Beings93969130.440034ChildD002675Living Beings65236080.594942Child, PreschoolD003630Chemicals & Drugs23780.969474DaunorubicinD003561Chemicals & Drugs512180.93221CytarabineD007223Living Beings60430360.61304InfantD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleAuthorship 4256914D006801Living Beings2262862810.130052HumansD014212Chemicals & Drugs681250.932903TretinoinD008297Physiology1931408600.201617MaleMedicine-Hematology and OncologyD016896Concepts & Ideas101179490.402389Treatment OutcomeD009364Disorders33613050.61985Neoplasm Recurrence, Local0.09795910.09795911authors10.2522has subject areaD015473Disorders16490.961186Leukemia, Promyelocytic, AcuteD015996Concepts & Ideas45518560.724887Survival RateD005500Procedures76836160.590107Follow-Up StudiesD012074Procedures1657220.853019Remission InductionD055815Living Beings97159610.423207Young AdultUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessor